Get started
Author

Min‐Yen Lo

Observed name: Min-Yen Lo
ORCID: 0000-0001-8208-353X
Observed ORCID: 0000-0001-8208-353X
OpenAlex ID: A5016393748
Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia
2023 · Min‐Yen Lo, Xavier Cheng‐Hong Tsai, et al. · American Journal of Hematology · 48
PDF
Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML
2023 · Xavier Cheng-Hong Tsai, Kuo-Jui Sun, et al. · Blood Cancer Journal · 46
PDF
Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification
2023 · Wan-Hsuan Lee, Ming-Tao Tsai, et al. · Blood Cancer Journal · 36
PDF
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms
2024 · Wan-Hsuan Lee, Chien-Chin Lin, et al. · Blood Cancer Journal · 33
PDF
Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
2021 · Yu-Wen Wang, Xavier Cheng-Hong Tsai, et al. · Annals of Hematology · 28
Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations
2024 · Feng-Ming Tien, Chi-Yuan Yao, et al. · Blood Cancer Journal · 23
PDF
Clinico‐genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification
2023 · Wan‐Hsuan Lee, Chien‐Chin Lin, et al. · American Journal of Hematology · 14
PDF
Annotation-free deep learning for predicting gene mutations from whole slide images of acute myeloid leukemia
2025 · Bo-Han Wei, Xavier Cheng-Hong Tsai, et al. · npj Precision Oncology · 13
PDF
Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutations
2025 · Sao-Chih Ni, Chi-Yuan Yao, et al. · Blood Cancer Journal · 11
PDF
Prognostic impact of co-occurring FLT3 mutations across molecular subgroups in intensively treated acute myeloid leukemia: insights from real-world genomic data
2026 · Yu-Sung Chang, Feng-Ming Tien, et al. · Blood Cancer Journal · 6
PDF
Stellae-123 gene expression signature improved risk stratification in Taiwanese acute myeloid leukemia patients
2024 · Yu-Hung Wang, Adrián Mosquera Orgueira, et al. · Scientific Reports · 3
Prognostic implications of genetic and transcriptomic abnormalities in MDS according to IPSS-R, IPSS-M, and the International Consensus Classification
2026 · Wan-Hsuan Lee, Hsin-An Hou, et al. · Blood Cancer Journal · 1
PDF
Prognostic impact of lymphocyte to monocyte ratio in patients with myelodysplastic neoplasms/syndromes
2025 · Wan-Hsuan Lee, Chien-Chin Lin, et al. · Blood Research · 1
Epidemiology, Treatment Outcomes, and Prognosis of Myelodysplastic Syndromes/Neoplasms in Taiwan: Real-World Insights and Trends
2025 · Wan-Hsuan Lee, Chien-Chin Lin, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
Early post-transplant molecular residual disease predicts outcomes in myelodysplastic neoplasms/syndromes and acute myeloid leukemia undergoing allogeneic transplantation
2026 · Wan-Hsuan Lee, Xavier Cheng-Hong Tsai, et al. · Blood Cancer Journal
PDF
Divergent Clonal Trajectories of FLT3 ‐ITD in Acute Myeloid Leukemia and Their Clinical and Transcriptomic Associations
2026 · Xavier Cheng‐Hong Tsai, Yu‐Sung Chang, et al. · Hematological Oncology
PDF
POSTER: AML-468: DNMT3A Co-Mutation and Immune Exclusion Signatures Define Outcomes in AML With IDH2 Mutations
2026 · Feng-Ming Tien, Chi-Yuan Yao, et al. · Clinical Lymphoma Myeloma & Leukemia
AML-468: DNMT3A Co-Mutation and Immune Exclusion Signatures Define Outcomes in AML With IDH2 Mutations
2026 · Feng-Ming Tien, Chi-Yuan Yao, et al. · Clinical Lymphoma Myeloma & Leukemia
Myelodysplastic Syndromes/Neoplasms with Coexisting Autoimmune Disease Are Characterized by Immune Activation and Inferior Survival
2026 · Tai-Chung Tseng, Wan-Hsuan Lee, et al. · SSRN Electronic Journal
Prognostic Implications of Myelodysplasia-Related Gene Mutations in NPM1-Mutated Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis
2025 · Yu-Sung Chang, Yi-Wei Lee, et al.
PDF
P721: Validation of the Molecular International Prognostic Scoring System in Patients With Myelodysplastic Syndromes Defined by International Consensus Classification
2023 · Wan Hsuan Lee, Ming-Daw Tsai, et al. · HemaSphere
Works count: 21
Citation count: 264
H-index: 9
I10-index: 9
Year
Topic
Type